- name: Consortium-wide publications
  id: 
  pubs:

    - author: '**First VIMC-wide publication.** Li, X. et al.'
      year: 2021
      title:  'Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study'
      info:   'The Lancet, 397:398-408. doi:10.1016/S0140-6736(20)32657-X'
      url:    'https://doi.org/10.1016/S0140-6736(20)32657-X'

    - author: 'VIMC methodological paper. 
    Echeverria Londono, S., Li X., Toor, J., de Villiers, M.J., Nayagam, S., Hallett, T.B., Abbas, K., Jit, M., Klepac, P., Jean, K., Garske, T., Ferguson, N.M., Gaythorpe, K.A.M.' 
      year: 2021
      title:  'How can the public health impact of vaccination be estimated?'
      url:    'https://www.medrxiv.org/content/10.1101/2021.01.08.21249378v1'
      
    - author: 'Pre-print of VPD-COVID phase 1 paper.
      Gaythorpe, K., Abbas, K., Huber, J., Karachaliou, A., Thakkar, N., Woodruff, K., Li, X., Echeverria-Londono, S., VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, Ferrari, M., Jackson, M.L.,  McCarthy, K., Perkins, A.,  Trotter, C., Jit, M.'
      year: 2021
      title:  'Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries'
      url:    'https://www.medrxiv.org/content/10.1101/2021.01.25.21250489v1'
      
- name: Cholera 
  id: cholera
  pubs:
    - author: 'Lee, EC., Azman, AS., Kaminsky, J., Moore, S.M., McKay, H.S., Lessler, J.'
      year:   2019
      title:  'The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study'
      info:   'PLOS Medicine 11 Dec 2019'
      url:    ' https://doi.org/10.1371/journal.pmed.1003003'

- name: Hepatitis B
  id: hep-b
  pubs:
    - author: 'Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S.'
      year:   2005
      title:  'A mathematical model to estimate global hepatitis B disease burden and vaccination impact'
      info:   'Int J Epidemiol, 34(6), 1329-1339. doi:10.1093/ije/dyi206'
      url:    'https://www.ncbi.nlm.nih.gov/pubmed/16249217'

    - author: 'Nayagam, S., Thursz, M., Sicuri, E., Conteh, L., Wiktor, S., Low-Beer, D. L., & Hallett, T. B.'
      year:   2016
      title:  'Requirements for global elimination of hepatitis B: a modelling study' 
      info:   'Lancet Infectious Diseases, 16(12), 1399-1408'
      url:    'http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(16)30204-3/abstract'

    - author: Li, X., Wiesen, E., Diorditsa, S., Toda, K., Duong, T. H., Nguyen, L. H., Nguyen, T. H.
      year:   2016
      title:  Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection
      info:   Vaccine, 34(6), 869-873. doi:10.1016/j.vaccine.2015.05.067
      url:    https://www.ncbi.nlm.nih.gov/pubmed/26055296

    - author: Wiesen, E., Diorditsa, S., & Li, X.
      year:   2016
      title:  Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014
      info:   Vaccine, 34(25), 2855-2862
      url:    https://www.ncbi.nlm.nih.gov/pubmed/27020710

- name: 'Haemophilus influenzae type b (Hib), rotavirus and pneumococcal disease'
  id: hib
  pubs:
    - author: Bourgeois, A. L., Wierzba, T. F., & Walker, R. I.
      year:   2016
      title:  Status of vaccine research and development for enterotoxigenic Escherichia coli
      info:   Vaccine, 34(26), 2880-2886. doi:10.1016/j.vaccine.2016.02.076
      url:    https://www.ncbi.nlm.nih.gov/pubmed/26988259

    - author: Clark, A., Jauregui, B., Griffiths, U., Janusz, C. B., Bolanos-Sierra, B., Hajjeh, R., Sanderson, C.
      year:   2013
      title:  TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination
      info:   Vaccine, 31 Suppl 3, C19-29. doi:10.1016/j.vaccine.2013.05.045
      url:    http://about.elsevier.com/vaccine/PAHO_14270_Clark.pdf

    - author: Jit, M., Huyen, D. T. T., Friberg, I., Van Minh, H., Kiet, P. H. T., Walker, N., & Fox, K. 
      year:   2015
      title:  'Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization'
      info:   Vaccine, 33, A233-A239
      url:    https://jhu.pure.elsevier.com/en/publications/thirty-years-of-vaccination-in-vietnam-impact-and-cost-effectiven-3

    - author: Walker, N., Tam, Y., & Friberg, I. K.
      year:   2013
      title:  Overview of the Lives Saved Tool (LiST)
      info:   BMC Public Health, 13 Suppl 3, S1. doi:10.1186/1471-2458-13-S3-S1
      url:    https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-S3-S1

- name: Human papillomavirus (HPV)
  id: hpv
  pubs:
    - author: Ochalek J, Abbas K, Claxton K, Jit M, Lomas J.
      year:   2020
      title:  'Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries'
      info:   BMJ Glob Health
      url:    https://gh.bmj.com/content/5/10/e003006 
      
    - author: Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ.
      year:   2020
      title:  'Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries'
      info:   International Journal of Cancer
      url:    https://onlinelibrary.wiley.com/doi/10.1002/ijc.33233
      
    - author: Portnoy A, Clark S, Ozawa S, Jit M.
      year:   2020
      title:  'The impact of vaccination on gender equity: conceptual framework and human papillomavirus (HPV) vaccine case study'
      info:   International Journal for Equity in Health
      url:    https://equityhealthj.biomedcentral.com/articles/10.1186/s12939-019-1090-3
      
    - author: Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ.
      year:   2020
      title:  'Impact and cost-effectiveness of human papillomavirus'
      info:   Vaccination campaigns
      url:    https://cebp.aacrjournals.org/content/29/1/22

    - author: Brisson M, Kim J, Canfell K, Drolet M, Gingras G, Burger EA, et al.
      year:   2020
      title:  'Impact of HPV Vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries'
      info:   Lancet 2020; 395: 575-90
      url:    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30068-4/fulltext
  
    - author: Jit, M., Brisson, M., Portnoy, A., & Hutubessy, R.
      year:   2014
      title:  'Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study'
      info:   Lancet Global Health, 2(7), E406-E414
      url:    http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(14)70237-2/abstract

    - author: Kim, J. J., Sharma, M., O'Shea, M., Sweet, S., Diaz, M., Sancho-Garnier, H., & Seoud, M. 
      year:   2013
      title:  Model-Based Impact and Cost-Effectiveness of Cervical Cancer Prevention in the Extended Middle East and North Africa (EMENA)
      info:   Vaccine, 31, G65-G77
      url:    https://www.ncbi.nlm.nih.gov/pubmed/24331822

    - author: Kim, S. Y., Sweet, S., Chang, J., & Goldie, S. J.
      year:   2011
      title:  'Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden'
      info:   BMC Infect Dis, 11, 174. doi:10.1186/1471-2334-11-174
      url:    https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-11-174
      
    - author: Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S. Y. 
      year:   2008
      title:  Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries
      info:   Vaccine, 26(32), 4080-4093
      url:    https://www.ncbi.nlm.nih.gov/pubmed/18550229


- name: Japanese encephalitis
  id: je
  pubs:
    - author: Quan TM, Thao TTN, Duy NM, Nhat TM, Clapham H. 
      year:   2020
      title:  'Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015'
      info:   Elife. 2020;9:e51027. doi:10.7554/eLife.51027.
      url:    https://elifesciences.org/articles/51027

- name: Measles
  id: measles
  pubs:
    - author: Chen, S., Fricks, J., & Ferrari, M. J. 
      year:   2012
      title:  Tracking measles infection through non-linear state space models
      info:   Journal of the Royal Statistical Society Series C-Applied Statistics, 61, 117-134
      url:    http://onlinelibrary.wiley.com/doi/10.1111/j.1467-9876.2011.01001.x/abstract

    - author: Simons, E., Ferrari, M., Fricks, J., Wannemuehler, K., Anand, A., Burton, A., & Strebel, P. 
      year:   2012
      title:  'Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data'
      info:   Lancet, 379(9832), 2173-2178. doi:10.1016/S0140-6736(12)60522-4
      url:    https://www.ncbi.nlm.nih.gov/pubmed/22534001

    - author: Verguet, S., Johri, M., Morris, S. K., Gauvreau, C. L., Jha, P., & Jit, M. 
      year:   2015
      title:  'Controlling measles using supplemental immunization activities: A mathematical model to inform optimal policy'
      info:   Vaccine, 33(10), 1291-1296
      url:    http://www.sciencedirect.com/science/article/pii/S0264410X14016077

- name: Meningitis A
  id: men-a
  pubs:
    - author: Oumar, A. D., Isaie, M., Wilfried, B. B., Yameogo, I., Koussoube, D., Ouedraogo, R., Sangare, L., & Mbaeyi, S. A.  
      year:   2018
      title:  Initial validation of a simulation model for estimating the impact of serogroup A Neisseria meningitidis vaccination in the African meningitis belt
      info:   PLoS One, 13(10), e0206117. doi:10.1371/journal.pone.0206117 
      url:    https://doi.org/10.1371/journal.pone.0206117
  
    - author: Colombini, A., Trotter, C., Madrid, Y., Karachaliou, A., & Preziosi, M. P. 
      year:   2015
      title:  Costs of Neisseria meningitidis Group A Disease and Economic Impact of Vaccination in Burkina Faso
      info:   Clin Infect Dis, 61 Suppl 5, S473-482. doi:10.1093/cid/civ600
      url:    https://www.ncbi.nlm.nih.gov/pubmed/26553677

    - author: Karachaliou, A., Conlan, A. J., Preziosi, M. P., & Trotter, C. L. 
      year:   2015
      title:  Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
      info:   Clin Infect Dis, 61 Suppl 5, S594-600. doi:10.1093/cid/civ508
      url:    https://www.ncbi.nlm.nih.gov/pubmed/26553693

    - author: Tartof, S., Cohn, A., Tarbangdo, F., Djingarey, M. H., Messonnier, N., Clark, T. A.,  Jackson, M. L. 
      year:   2013
      title:  Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt
      info:   PLoS One, 8(5), e63605. doi:10.1371/journal.pone.0063605
      url:    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063605

- name: Rubella
  id: rubella
  pubs:
    - author: Vynnycky, E., Adams, E. J., Cutts, F. T., Reef, S. E., Navar, A. M., Simons, E., Dabbagh, A. J.
      year:   2016
      title:  'Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.'
      info:   PLoS One, 11(3)
      url:    http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149160

    - author: Vynnycky, E., Yoshida, L. M., Huyen, D. T. T., Trung, N. D., Toda, K., Cuong, N. V., Hien, N. T.
      year:   2016
      title:  Modeling the impact of rubella vaccination in Vietnam
      info:   Human Vaccines & Immunotherapeutics, 12(1), 150-158
      url:    https://www.ncbi.nlm.nih.gov/pubmed/26260857

- name: Yellow Fever
  id: yellow-fever
  pubs:
    - author: Perkins, A., Huber, J. H., Tran, Q. M., Oidtman, R. J., Walters, M. K., Siraj, A. S., Moore, S. M.
      year:   2021
      title:  'Burden is in the eye of the beholder: Sensitivity of yellow fever disease burden estimates to modeling assumptions'
      info:   medRxiv
      url:    https://www.medrxiv.org/content/10.1101/2021.01.06.21249311v1
      
    - author: Jean, K., Raad H., Gaythorpe, K., Hamlet, A., Mueller, J. E., Hogan, D., Mengistu, T., Whitaker, H. J., Hocine, M. N.
      year:   2020
      title:  'Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa : a population-level self-controlled case-series study'
      info:   medRxiv
      url:    https://www.medrxiv.org/content/10.1101/2020.07.09.20147355v1
      
    - author: Gaythorpe, K., Hamlet, A., Jean, K., Ramos, D. G., Cibrelus, L., Garske, T., Ferguson, N.
      year:   2020
      title:  'The global burden of yellow fever'
      info:   medRxiv
      url:    https://www.medrxiv.org/content/10.1101/2020.10.14.20212472v1
      
    - author: Gaythorpe KAM, Hamlet A, Cibrelus L, Garske T, Ferguson, N.
      year:   2020
      title:  'The effect of climate change on yellow fever disease burden in Africa'
      info:   elife
      url:    https://elifesciences.org/articles/55619
          
    - author: Jean K, Hamlet A, Benzler J, Cibrelus L, Gaythorpe K , Sall A, Ferguson N, Garske, T.
      year:   2020
      title:  'Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling'
      info:   PLOS Med
      url:    https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008304
           
    - author:  Garske, T., Van Kerkhove, M. D., Yactayo, S., Ronveaux, O., Lewis, R. F., Staples, J. E., Comm, Y. F. E.
      year:   2014
      title:  'Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data'
      info:   PLoS Med, 11(5)
      url:    http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001638

    - author: Jean, K., Donnelly, C. A., Ferguson, N. M., & Garske, T
      year:   2016
      title:  'A Meta-Analysis of Serological Response Associated with Yellow Fever Vaccination'
      info:   Am J Trop Med Hyg, 95(6), 1435-1439. doi:10.4269/ajtmh.16-0401
      url:    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154464/
      
      
- name: VPD-COVID publications
  id: 
  pubs:

    - author: 'Pre-print of VPD-COVID phase 1 paper.
      Gaythorpe, K., Abbas, K., Huber, J., Karachaliou, A., Thakkar, N., Woodruff, K., Li, X., Echeverria-Londono, S., VIMC Working Group on COVID-19 Impact on Vaccine Preventable Disease, Ferrari, M., Jackson, M.L.,  McCarthy, K., Perkins, A.,  Trotter, C., Jit, M.'
      year: 2021
      title:  'Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries'
      url:    'https://www.medrxiv.org/content/10.1101/2021.01.25.21250489v1'
